Pharmacist recognition of potential drug interactions

American Journal of Health-System Pharmacy

Volumn 56, Issue 15, 1999, Pages 1524-1529

  Weideman, Rick A ^a,b   Bernstein, Ira H ^c   McKinney, W Paul ^d   Cooke, V V ^e  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e University of Louisville School of Medicine   (United States)

Author keywords

Drug interactions; Education, pharmaceutical; Errors, medication; Pharmacists, hospital; Pharmacy; Pharmacy, institutional, hospital; Prescribing

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG INTERACTION; DRUG SCREENING; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL EDUCATION; PHARMACY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0033180271     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.15.1524     Document Type: Article

References (19)

1. Hartshorn EA, Tatro DS. Principles of drug interactions. In: Tatro DS, ed. Drug interaction facts. 5th ed. St. Louis: Facts and Comparisons; 1996:xix.
2. Karas S. The potential for drug interactions. Ann Emerg Med. 1981; 10:627-30.
3. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA. 1996; 275:1086. Letter.
4. Bates DW, Leape LL. Reply. (Pharmacies and prevention of potentially fatal drug interactions.) JAMA. 1996; 275:1086-7.
5. Jankel CA, Speedie SM, McMillan JA. The effectiveness of computerized drug interaction screening programs in hospitals. Drug Inf J. 1990; 24:513-29.
6. Kinney EL. Expert system detection of drug interactions: results in consecutive inpatients. Comput Biomed Res. 1986; 19: 462-7.
7. Jankel CA, Martin BC. Evaluation of six computerized drug interaction screening programs. Am J Hosp Pharm. 1992; 49: 1430-5.
8. Poirier TI, Givdici RA. Evaluation of drug interaction micro-computer software comparative study. Hosp Pharm. 1991; 26: 30-4.
9. Macmillan NA, Creelman CD. Detection theory: a user's guide. Cambridge, England: Cambridge Univ. Press; 1991.
10. Swets JA. Indices of discrimination or diagnostic accuracy: their ROCs and implied models. Psychol Bull. 1986; 99:100-17.
11. Green DM, Swets JA. Signal detection theory and psychophysics. New York: Wiley; 1967.
12. Winer BJ, Brown DR, Michels KM. Statistical principles in experimental design. 3rd ed. New York: McGraw-Hill; 1991:271-3.
13. Weideman RA, McKinney WP, Bernstein IH. Predictors of potential drug interactions. Hosp Pharm. 1998; 33:835-40.
14. Williams KG. Pharmacists' duty to warn of drug interactions. Am J Hosp Pharm. 1992; 49:2787-9.
15. Lazarou J, Pomerance BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279:1200-5.
16. Johnson JA, Bootman JL. Drug-related morbidity and mortality. Arch Intern Med. 1995; 155:1949-56.
17. Bates DW, Spell N, Cullen DJ. Costs of adverse drug events in hospitalized patients. JAMA. 1997; 277:307-11.
18. Cadieux RJ. Drug interactions in the elderly: how multiple drug use increases risk exponentially. Postgrad Med. 1989; 86:179-86.
19. Lamy PP. The elderly and drug interactions. J Am Geriatr Soc. 1986; 34:586-92.